JelikaLite is a clinical stage medical technology company developing a transformational neuromodulation platform for unmet needs in developmental pediatric disorders. Our lead product is focused on Autism Spectrum Disorder (ASD).

ASD is a lifelong developmental disorder. The rates continue to rise, the cause remains unknown, and current solutions are inadequate. Autistic individuals frequently have difficulties with communication, social interactions, repetitive behavior and focus, impacting their ability to integrate into society. We believe that all children can lead fulfilling and productive lives.

That is why we are developing Cognilum, an innovative solution to enhance the child's communication skills while reducing a child's troublesome autism symptoms, enabling them to improve their lives. Cognilum is a therapeutic wearable device, providing non-invasive brain stimulation with near-infrared light, sensors and a machine learning personalization platform.

Our Team

Katya Sverdlov, CFA, Esq

CEO, Co-Founder

Over 20 years of financial, legal and start up experience

Eugenia Steingold, PhD

CSO, Co-Founder

Over 20 years of working with autistic children, both in therapy and research

Liza Logounova

COO

Over 20 years experience in managing product and platform development

Luis DeTaboada, MS

Technology Lead

CTO of LiteCure
Specialist in transcranial photobiomodulation, medical devices, physics, and lasers

Ali Mostashari, PhD

AI Lead

CEO and Co-Founder, LifeNome: precision health AI company
Member of World Economic Forum

Dr. Michael Hamblin

Advisor

Associate professor at Harvard Medical School and an Associate Chemist in Massachusetts General Hospital
He is a world leading specialist on photobiomodulation, with over 280 peer-reviewed publications, mostly on phototherapy.

Anne-Marie Maman

Advisor

Executive Director, Princeton Entrepreneurship Council at Princeton University. Founded 3 startup companies, each with innovative, leading-edge technology; licensed IP, led all aspects of the businesses, and negotiated acquisition of 1 company for nearly $10 million within 3 years of formation.